NCT01434316 2026-03-18
Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT01591356 2026-01-07
EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05038839 2025-11-20
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03537690 2025-08-12
FID-007 in Treating Participants With Advanced Solid Tumors
University of Southern California
Phase 1 Active not recruiting